Our company has a dedicated team and hands-on experience in drug safety evaluation, providing high-quality data and rapid turnaround to support a wide range of drug safety evaluation studies. Our toxicology studies are conducted on a variety of animal species, from dose design and experimental studies to histology and pathology studies. Our research platform has served many laboratories and pharmaceutical companies worldwide.
Service Overview
Our company can offer customers contract research services as well as toxicology services to assess the security of experimental medications. Small-molecule pharmaceuticals, biotechnology drugs, monovalent and polyvalent vaccinations, and herbal medicines are all tested by us. Our company is also able to offer a full suite of application materials for individual toxicology studies and outsourced non-clinical safety evaluation services.
Our technical service platforms for non-human primate experimental studies, our technical service platforms for protein crystallography-based drug discovery and screening, and our specialized technical service platforms for isotope drug metabolism studies are all used for the evaluation of the safety of our drugs.
Research Capabilities
Our company develops medications with an acceptable safety profile using an integrated, multidisciplinary approach. We use the following research to evaluate the safety of drugs.
- Pharmacology: Studies must take into account potential harmful effects brought on by drug-target interactions, such as interactions with unwanted molecular targets or molecular targets in unintended organs.
- Chemistry: The presence of side chains and chemical scaffolds in the medicine that raises safety questions must be taken into account.
- Toxicology: Both toxicity in relevant cultured animal and human cells as well as toxicity in live animals must be taken into account.
- Drug Metabolism and Pharmacokinetics: It is important to take into account safety concerns related to organ distribution, clearance, and pharmacokinetic drug-drug interactions.
- Risk Factors: It is important to take into account the physiological, environmental, and genetic aspects that could make a patient more susceptible.
Such an integrated, interdisciplinary approach to safety evaluation is advised since it can increase the precision of drug safety forecasts and, consequently, the effectiveness of drug development. From target identification to clinical trials, all stages of drug research and development make use of this thorough understanding of drug safety.
Overall Solutions
| Project Name | Basic Information Service for Drug Safety Evaluation |
| Service Details | Our company's preclinical department has expertise in drug metabolism/pharmacokinetics, pharmacokinetic studies, and toxicology. It provides high-quality data and rapid turnaround to support a variety of drug development, preclinical studies and clinical studies. Our basic information services for drug safety evaluation cover all aspects: protocol design, in vivo studies, sample analysis, specialized data analysis, IACUC review, and application data preparation. |
| Deliverables | Within agreed time, we will provide the summary to experiment data and conclusions, as well as a final experiment report. |
| Cycle | Decide according to your needs. |
For more information, please feel free to contact us.
Reference
- Eedara B. B, et al. (2021). "Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection." Pharmaceutics. 13(7): 1077.
Related Services
It should be noted that our service is only used for research, not for clinical use.
